Article Text
Abstract
Must medical experiments with human subjects offer them a ‘favourable risk-benefit ratio’, that is, more expectation of benefit than harm or burden, if they are to be judged as ethically justified? Ethical justification is easier for experiments that do offer net benefit to subjects, but ethical justification is possible also for some experiments that do not. Basic science experiments with healthy volunteers and ‘Phase I’ drug trials that seek to determine tolerable dosage levels are routinely approved by ethical review committees; moreover, guidance they receive from government funding agencies specifically asks them to weigh risks to subjects against benefits to subjects and also benefits to those who may benefit from the knowledge gained in the experiment. If a puzzle remains, it is why there remains any assumption that research ethics requires a ‘favourable risk-benefit ratio’ for the individual research subject.
- Research Ethics
- HIV Infection and AIDS
- Policy Guidelines/Inst. Review Boards/Review Cttes.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Funding National Institute of Allergy and Infectious Diseases (1 R01 AI114617-01A1, 1 R56 AI114617-01).
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed.
Other content recommended for you
- The morality of risks in research: reflections on Kumar
- Exploring the ethics of tuberculosis human challenge models
- Limits to research risks
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- Phase 1 oncology trials and informed consent
- Individual risk and community benefit in international research
- Refuting the net risks test: a response to Wendler and Miller’s “Assessing research risks systematically”
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Non-completion and informed consent
- Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls